Extranodal natural killer/T-cell lymphoma, nasal type, with prominent granulomatous reaction. 2014

Noriki Fujimoto, and Toshifumi Takahashi, and Mami Yamashita, and Gen Nakanishi, and Hidetoshi Okabe, and Toshihiro Tanaka
Department of Dermatology, Otsu, Shiga, Japan.

UI MeSH Term Description Entries
D007866 Leg The inferior part of the lower extremity between the KNEE and the ANKLE. Legs
D008297 Male Males
D006099 Granuloma A relatively small nodular inflammatory lesion containing grouped mononuclear phagocytes, caused by infectious and noninfectious agents. Granulomas
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D012867 Skin The outer covering of the body that protects it from the environment. It is composed of the DERMIS and the EPIDERMIS.
D012871 Skin Diseases Diseases involving the DERMIS or EPIDERMIS. Dermatoses,Skin and Subcutaneous Tissue Disorders,Dermatosis,Skin Disease
D054391 Lymphoma, Extranodal NK-T-Cell An extranodal neoplasm, usually possessing an NK-cell phenotype and associated with EPSTEIN-BARR VIRUS. These lymphomas exhibit a broad morphologic spectrum, frequent necrosis, angioinvasion, and most commonly present in the midfacial region, but also in other extranodal sites. Extranodal NK-T-Cell Lymphoma,Extranodal NK-T-Cell Lymphoma, Nasal,Extranodal NK-T-Cell Lymphoma, Nasal Type,Extranodal NK-T-Cell Lymphoma, Nasal and Nasal-Type,Extranodal NK T Cell Lymphoma,Extranodal NK T Cell Lymphoma, Nasal,Extranodal NK T Cell Lymphoma, Nasal Type,Extranodal NK T Cell Lymphoma, Nasal and Nasal Type,Extranodal NK-T-Cell Lymphomas,Lymphoma, Extranodal NK T Cell,Lymphomas, Extranodal NK-T-Cell,NK-T-Cell Lymphoma, Extranodal,NK-T-Cell Lymphomas, Extranodal
D017809 Fatal Outcome Death resulting from the presence of a disease in an individual, as shown by a single case report or a limited number of patients. This should be differentiated from DEATH, the physiological cessation of life and from MORTALITY, an epidemiological or statistical concept. Fatal Outcomes,Outcome, Fatal,Outcomes, Fatal

Related Publications

Noriki Fujimoto, and Toshifumi Takahashi, and Mami Yamashita, and Gen Nakanishi, and Hidetoshi Okabe, and Toshihiro Tanaka
January 2010, Advances in hematology,
Noriki Fujimoto, and Toshifumi Takahashi, and Mami Yamashita, and Gen Nakanishi, and Hidetoshi Okabe, and Toshihiro Tanaka
May 2008, Actas dermo-sifiliograficas,
Noriki Fujimoto, and Toshifumi Takahashi, and Mami Yamashita, and Gen Nakanishi, and Hidetoshi Okabe, and Toshihiro Tanaka
January 2022, Proceedings (Baylor University. Medical Center),
Noriki Fujimoto, and Toshifumi Takahashi, and Mami Yamashita, and Gen Nakanishi, and Hidetoshi Okabe, and Toshihiro Tanaka
January 2010, Skinmed,
Noriki Fujimoto, and Toshifumi Takahashi, and Mami Yamashita, and Gen Nakanishi, and Hidetoshi Okabe, and Toshihiro Tanaka
September 2017, Actas dermo-sifiliograficas,
Noriki Fujimoto, and Toshifumi Takahashi, and Mami Yamashita, and Gen Nakanishi, and Hidetoshi Okabe, and Toshihiro Tanaka
June 2015, Cornea,
Noriki Fujimoto, and Toshifumi Takahashi, and Mami Yamashita, and Gen Nakanishi, and Hidetoshi Okabe, and Toshihiro Tanaka
April 2022, Ear, nose, & throat journal,
Noriki Fujimoto, and Toshifumi Takahashi, and Mami Yamashita, and Gen Nakanishi, and Hidetoshi Okabe, and Toshihiro Tanaka
April 2018, International journal of dermatology,
Noriki Fujimoto, and Toshifumi Takahashi, and Mami Yamashita, and Gen Nakanishi, and Hidetoshi Okabe, and Toshihiro Tanaka
May 2015, Clinical lymphoma, myeloma & leukemia,
Noriki Fujimoto, and Toshifumi Takahashi, and Mami Yamashita, and Gen Nakanishi, and Hidetoshi Okabe, and Toshihiro Tanaka
January 2021, Case reports in hematology,
Copied contents to your clipboard!